{"transactions":[{"id":1508594,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2024-05-20T19:26:45.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0.53,"value":5300.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 2, 2024, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."}],"balance_after":33525,"derivative":{"exercise_price":0.53,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-063361","document":"tm2414962-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924063361/tm2414962-5_4seq1.xml","form_type":"4"}},{"id":1888420,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T16:27:33.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":125,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units (\"RSUs\") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":1326340,"source":{"system":"sec-edgar","filing":"0001104659-23-061737","document":"tm2315065-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923061737/tm2315065-2_4seq1.xml","form_type":"4"}},{"id":2022257,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-11T00:43:22.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":625,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying certain restricted stock units (\"RSUs\"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). 625 RSUs vested in one installment on December 31, 2022 and were settled on January 3, 2023, subject to the terms and conditions set forth in the RSU Agreement and as a result, 625 shares of common stock were issued to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company."}],"balance_after":1326215,"source":{"system":"sec-edgar","filing":"0001104659-23-018756","document":"tm236233-3_5seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923018756/tm236233-3_5seq1.xml","form_type":"5"}},{"id":2054443,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2023-01-13T17:58:54.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":10000,"price":1.41,"value":14100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":23525,"derivative":{"exercise_price":1.41,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-23-003742","document":"tm233286-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465923003742/tm233286-1_4seq1.xml","form_type":"4"}},{"id":2492939,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-11-30T01:01:04.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The derivative securities were awarded as compensation to the Reporting Person for his service as the director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the \"RSU Agreement\"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492938,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non-Qualified Stock Options","published_at":"2021-11-30T01:01:04.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":13525,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The derivative securities were awarded as compensation to the Reporting Person for his service as the director of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each non-qualified stock option (\"NSO\") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the \"Company\") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the \"NSO Agreement\") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement."}],"balance_after":13525,"derivative":{"underlying":"Common Stock","underlying_shares":13525},"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492937,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":1000,"price":5.19,"value":5190.0,"ownership":{"direct":false,"nature":"By Wingood Capital LLC"},"balance_after":1314524,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492936,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-11-15","kind":"purchase","acquired":true,"shares":500,"price":5.3,"value":2650.0,"ownership":{"direct":true},"balance_after":1313524,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492935,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-11-15","kind":"purchase","acquired":true,"shares":500,"price":5.29,"value":2645.0,"ownership":{"direct":true},"balance_after":1313024,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492934,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-11-10","kind":"purchase","acquired":true,"shares":500,"price":5.85,"value":2925.0,"ownership":{"direct":true},"balance_after":1312524,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492933,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-11-08","kind":"purchase","acquired":true,"shares":1000,"price":5.73,"value":5730.0,"ownership":{"direct":false,"nature":"By Wingood Capital LLC"},"balance_after":1312024,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492932,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-06-23","kind":"purchase","acquired":true,"shares":400,"price":6.52,"value":2608.0,"ownership":{"direct":true},"balance_after":1311024,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2492931,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-30T01:01:04.000Z","date":"2021-06-17","kind":"purchase","acquired":true,"shares":100,"price":6.27,"value":627.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Including 1,310,524 shares of common stock acquired by the Reporting Person on June 21, 2021, as reported in the Form 4 filed with the Securities and Exchange Commission on June 23, 2021."}],"balance_after":1310624,"source":{"system":"sec-edgar","filing":"0001104659-21-144593","document":"tm2134159-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921144593/tm2134159-1_4seq.xml","form_type":"4"}},{"id":2656822,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Bridge Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":13985,"ownership":{"direct":false,"nature":"By Andrew L. Ross 2013 Irrevocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":13985},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656821,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Bridge Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":86438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":86.438},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656820,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Bridge Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"other","acquired":true,"shares":39,"ownership":{"direct":false,"nature":"By Andrew L. Ross 2013 Irrevocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"shares","element":"transactionShares","label":"F11","text":"Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 13,985 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":13985,"derivative":{"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":39},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656819,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Bridge Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"other","acquired":true,"shares":2420,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"shares","element":"transactionShares","label":"F11","text":"Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The bridge note has a maturity date of June 30, 2021 and automatically converted into 100,423 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":86438,"derivative":{"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":2420},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656818,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":360674,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":360674},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656817,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"other","acquired":true,"shares":231,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"shares","element":"transactionShares","label":"F10","text":"Represents accrued interest from June 17, 2021 to June 21, 2021 under the convertible note."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The convertible note has a maturity date of June 30, 2021 and automatically converted into 360,674 shares of common stock at $5.60 upon the closing of the IPO."}],"balance_after":360674,"derivative":{"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":231},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656816,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":130081,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Shares of Series B Preferred Stock automatically converted into shares of common stock upon the closing of the IPO and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":130081},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656815,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":355005,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the \"IPO) and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":355005},"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656814,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":13985,"ownership":{"direct":false,"nature":"By Andrew L. Ross 2013 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person."}],"balance_after":1310524,"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656813,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":86438,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares were issued to the reporting person upon conversion of an aggregate of $562,375 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person."}],"balance_after":1296539,"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656812,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":360674,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were issued to the reporting person upon conversion of an aggregate of $2,019,797 in principal and accrued interest through June 21, 2021 under a convertible note owed to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares were issued to the reporting person upon conversion of an aggregate of $2,019,797 in principal and accrued interest through June 21, 2021 under a convertible note owed to the reporting person."}],"balance_after":1210101,"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656811,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":130081,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series B Preferred Stock owned through the date of conversion."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series B Preferred Stock owned through the date of conversion."}],"balance_after":849427,"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}},{"id":2656810,"issuer":{"id":8372,"kind":"organization","name":"iSpecimen Inc."},"owners":[{"id":90805,"kind":"person","name":"Ross Andrew L.","position":1,"cik":"0001857013","reported_name":"Ross Andrew L.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T01:35:54.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":355005,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion."}],"balance_after":719346,"source":{"system":"sec-edgar","filing":"0001104659-21-084775","document":"tm2120463-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465921084775/tm2120463-1_4seq1.xml","form_type":"4"}}]}